Anfarm Hellas S.A. - Main Component
Active Substance | Strength | Form |
---|---|---|
Acyclovir | 5% (Tubx10g) | Cr.Ext.Us |
Alendronic acid | 70mg | Tab |
Ambroxol HCl | 15mg/5ml (125ml Bottle) | Syr Infant |
Ambroxol HCl | 30mg/5ml (125ml, 250ml Bottles) | Syr |
Amikacin | 500mg/2ml | Inj.Sol |
Amikacin | 1g/4ml | Inj.Sol |
ApixabanUnder Development | 2.5mg/tab & 5mg/tab | F.C.Tabs |
Atorvastatin | 20mg, 40mg | F.C.Tab |
Azithromycin | 500mg/Vial | Pd.Sol.Inf |
Azithromycin | 250mg, 500mg, 600mg | F.C.Tab |
Active Substance | Strength | Form |
---|---|---|
Acyclovir | 5% (Tubx10g) | Cr.Ext.Us |
Alendronic acid | 70mg | Tab |
Ambroxol HCl | 15mg/5ml (125ml Bottle) | Syr Infant |
Ambroxol HCl | 30mg/5ml (125ml, 250ml Bottles) | Syr |
Amikacin | 500mg/2ml | Inj.Sol |
Amikacin | 1g/4ml | Inj.Sol |
ApixabanUnder Development | 2.5mg/tab & 5mg/tab | F.C.Tabs |
Atorvastatin | 20mg, 40mg | F.C.Tab |
Azithromycin | 500mg/Vial | Pd.Sol.Inf |
Azithromycin | 250mg, 500mg, 600mg | F.C.Tab |
Active Substance | Strength | Form | Market Availability |
---|---|---|---|
Acyclovir | 5% (Tubx10g) | Cr.Ext.Us | Selected Markets |
Alendronic acid | 70mg | Tab | Selected Markets |
Ambroxol HCl | 15mg/5ml (125ml Bottle) | Syr Infant | Selected Markets |
Ambroxol HCl | 30mg/5ml (125ml, 250ml Bottles) | Syr | Selected Markets |
Amikacin | 500mg/2ml | Inj.Sol | International |
Amikacin | 1g/4ml | Inj.Sol | International |
ApixabanUnder Development | 2.5mg/tab & 5mg/tab | F.C.Tabs | Q4 2023 |
Atorvastatin | 20mg, 40mg | F.C.Tab | Selected Markets |
Azithromycin | 500mg/Vial | Pd.Sol.Inf | International |
Azithromycin | 250mg, 500mg, 600mg | F.C.Tab | Selected Markets |